29th Jul 2021 16:28
Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 19 July 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,431,781 | 10.7499 GBP | 10.6900 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
256,887 | 10.7482 GBP | 10.6900 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Short Position | 51,516 2,607 5,240 4,489 6,761 2,504 7,625 10,128
3,935 51,271 9,544 4,563
130 12,175 1,729 44 790 558 5,202 1 3,251 8,581 7,865
4,809 5,000 52,931 100,000 522
332,354 | 10.7001 GBP 10.7047 GBP 10.7083 GBP 10.7101 GBP 10.7164 GBP 10.7271 GBP 10.7301 GBP 10.7499 GBP
10.7058 GBP 10.7108 GBP 10.7174 GBP 10.7298 GBP
10.6995 GBP 10.6998 GBP 10.7000 GBP 10.7050 GBP 10.7053 GBP 10.7078 GBP 10.7081 GBP 10.7100 GBP 10.7107 GBP 10.7117 GBP 10.7193 GBP
10.7002 GBP 10.7013 GBP 10.7045 GBP 10.7156 GBP 10.7204 GBP
10.7261 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 29 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L